Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes

Authors: Heller, Simon, Battelino, Tadej, Bailey, Timothy S., Pieber, Thomas R., Hövelmann, Ulrike, Plum‐Mörschel, Leona, Melgaard, Anita E., Aronson, Ronnie, DiMeglio, Linda A., Johansen, Thue, Danne, Thomas

Source: Diabetes, obesity & metabolism. 25(5):1351-1360

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100178753193.0x000001&indx=1&recIds=ETOCvdc_100178753193.0x000001

Progressive Acceleration of Insulin Exposure Over 7 Days of Infusion Set Wear

Authors: Kastner, Jasmin R., Bailey, Timothy S., Strange, Poul, Shi, Leon, Oberg, Keith A., Strasma, Paul J., Joseph, Jeffrey I., Muchmore, Douglas B.

Source: Diabetes technology & therapeutics. 25(2):143-147

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100176159151.0x000001&indx=1&recIds=ETOCvdc_100176159151.0x000001

Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial

Authors: Brazg, Ron, Garg, Satish K., Bhargava, Anuj, Thrasher, James R., Latif, Kashif, Bode, Bruce W., Bailey, Timothy S., Horowitz, Barry S., Cavale, Arvind, Kudva, Yogish C., Kaiserman, Kevin B., Grunberger, George, Reed, John Chip, Chattaraj, Sarnath, Zhang, Gina, Shin, John, Chen, Vivian, Lee, Scott W., Cordero, Toni L., Rhinehart, Andrew S., Vigersky, Robert A., Buckingham, Bruce A.

Source: Diabetes technology & therapeutics. 24(8):535-543

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100166495371.0x000001&indx=1&recIds=ETOCvdc_100166495371.0x000001

Real‐world outcomes of addition of insulin glargine 300 U/mL (Gla‐300) to glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) therapy in people with type 2 diabetes: The DELIVER‐G study

Authors: Bailey, Timothy S., Gill, Jasvinder, Jones S., Merwyn, Shenoy, Laxmi, Nicholls, Charlie, Westerbacka, Jukka

Source: Diabetes, obesity & metabolism. 24(8):1617-1622

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100155256008.0x000001&indx=1&recIds=ETOCvdc_100155256008.0x000001

Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study

Authors: Garg, Satish K., Liljenquist, David, Bode, Bruce, Christiansen, Mark P., Bailey, Timothy S., Brazg, Ronald L., Denham, Douglas S., Chang, Anna R., Akturk, Halis Kaan, Dehennis, Andrew, Tweden, Katherine S., Kaufman, Francine R.

Source: Diabetes technology & therapeutics. 24(2):84-92

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100140429719.0x000001&indx=1&recIds=ETOCvdc_100140429719.0x000001

Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes

Authors: Garg, Satish K., Kipnes, Mark, Castorino, Kristin, Bailey, Timothy S., Akturk, Halis Kaan, Welsh, John B., Christiansen, Mark P., Balo, Andrew K., Brown, Sue A., Reid, Jennifer L., Beck, Stayce E.

Source: Diabetes technology & therapeutics. 24(6):373-380

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100151382106.0x000001&indx=1&recIds=ETOCvdc_100151382106.0x000001

A Comparative Study of Dasiglucagon Ready-to-Use Autoinjector and Glucagon Emergency Kit During Rescue from Simulated Severe Hypoglycemia

Authors: Bailey, Naila Celeste, Dimsits, Jeannett, Hammer, Mette, Kendall, David M., Bailey, Timothy S.

Source: Diabetes technology & therapeutics. 24(4):231-240

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100146831242.0x000001&indx=1&recIds=ETOCvdc_100146831242.0x000001

Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study

Authors: Bailey, Timothy S., Evenou, Pierre, Gill, Jasvinder, Berhanu, Paulos, Raymond, Romain, Strong, Jodi, Wright, Eugene E.

Source: Diabetes spectrum. 34(4):407-418

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN628353565&indx=1&recIds=ETOCRN628353565

Dasiglucagon, a next‐generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double‐blind trial

Authors: Bailey, Timothy S., Willard, Julie, Klaff, Leslie J., Yager Stone, Jenine, Melgaard, Anita, Tehranchi, Ramin

Source: Diabetes, obesity & metabolism. 23(10):2329-2335

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100128929024.0x000001&indx=1&recIds=ETOCvdc_100128929024.0x000001

Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations

Authors: Bailey, Timothy S., Alva, Shridhara

Source: Diabetes technology & therapeutics. 23(3):S-5-S-11

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100137082476.0x000001&indx=1&recIds=ETOCvdc_100137082476.0x000001

Improvement in Patient-Reported Outcomes in Adults with Type 1 Diabetes Treated with Sotagliflozin plus Insulin Versus Insulin Alone

Authors: Danne, Thomas, Joish, Vijay N., Afonso, Marion, Banks, Phillip, Sawhney, Sangeeta, Lapuerta, Pablo, Davies, Michael J., Buse, John B., Lin, Dee, Reaney, Matthew, Guillonneau, Sophie, Snoek, Frank J., Bailey, Timothy S., Polonsky, William H.

Source: Diabetes technology & therapeutics. 23(1):70-77

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100151019884.0x000001&indx=1&recIds=ETOCvdc_100151019884.0x000001

A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

Authors: Meneghini, Luigi F., Sullivan, Sean D., Oster, Gerry, Busch, Robert, Cali, Anna M. G., Dauchy, Arnaud, Gill, Jasvinder, Bailey, Timothy S.

Source: Diabetes, obesity & metabolism. 22(11):2004-2012

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111610013.0x000001&indx=1&recIds=ETOCvdc_100111610013.0x000001

Insulin glargine 300 U/mL versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 12‐month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real‐life clinical trial

Authors: Meneghini, Luigi, Blonde, Lawrence, Gill, Jasvinder, Dauchy, Arnaud, Bacevicius, Andrius, Strong, Jodi, Bailey, Timothy S.

Source: Diabetes, obesity & metabolism. 22(11):1995-2003

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111609927.0x000001&indx=1&recIds=ETOCvdc_100111609927.0x000001

Benefits and limitations of continuous glucose monitoring in type 1 diabetes

Authors: Stone, Jenine Y, Bailey, Timothy S

Source: Expert review of endocrinology & metabolism. 15(1):41-49

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100098589841.0x000001&indx=1&recIds=ETOCvdc_100098589841.0x000001

Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal‐bolus insulin regimens in treat‐to‐target trials: A narrative review.

Authors: Russell‐Jones, David^1,2 davidrussell‐jones@nhs.net, Bailey, Timothy S.³, Lane, Wendy⁴, Mathieu, Chantal⁵, Pedersen‐Bjergaard, Ulrik⁶

Source: Diabetic Medicine. Jul2024, Vol. 41 Issue 7, p1-12. 12p.

Subject Terms: *INSULIN therapy, *TYPE 1 diabetes, *GLYCOSYLATED hemoglobin, *DISEASE management, *PHARMACEUTICAL chemistry, *INSULIN, *INSULIN pumps, *INJECTIONS, *HYPOGLYCEMIA, *BLOOD sugar monitoring

Reduced Hypoglycemia and Comparable Efficacy with Insulin Glargine 300 U/ML Versus Insulin Glargine 100 U/ML in Patients with Type 2 Diabetes Achieving Different Levels of Prebreakfast Self-Monitored Plasma Glucose

Authors: Bailey, Timothy S. ^*, Odugbesan, Ola, Gill, J.K., Nikonova, Elena V., Chao, Jason, Reid, Timothy

Source: In Endocrine Practice November 2018 24(11):973-981

Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial

Authors: Blonde, Lawrence, Bailey, Timothy S., Chao, Jason, Dex, Terry A., Frias, Juan Pablo, Meneghini, Luigi F., Roberts, Michelle, Aroda, Vanita R.

Source: Advances in therapy. 36(9):2310-2326

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100124728519.0x000001&indx=1&recIds=ETOCvdc_100124728519.0x000001

Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient‐level pooled analysis of EDITION 1, 2 and 3

Authors: Bonadonna, Riccardo C., Yale, Jean‐François, Brulle‐Wohlhueter, Claire, Boëlle‐Le Corfec, Emmanuelle, Choudhary, Pratik, Bailey, Timothy S.

Source: Diabetes, obesity & metabolism. 21(3):715-719

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100093698309.0x000001&indx=1&recIds=ETOCvdc_100093698309.0x000001

Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real‐world results from the DELIVER Naïve cohort study

Authors: Bailey, Timothy S., Zhou, Fang L., Gupta, Rishab A., Preblick, Ronald, Gupta, Vineet E., Berhanu, Paulos, Blonde, Lawrence

Source: Diabetes, obesity & metabolism. 21(7):1596-1605

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100083016254.0x000001&indx=1&recIds=ETOCvdc_100083016254.0x000001

Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3)

Authors: Bailey, Timothy S., Wu, Jasmanda, Zhou, Fang L., Gupta, Rishab A., Menon, Arjun A., Berhanu, Paulos, Westerbacka, Jukka, Van Vleet, John, Blonde, Lawrence

Source: Diabetes, obesity & metabolism. 21(11):2384-2393

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100090977886.0x000001&indx=1&recIds=ETOCvdc_100090977886.0x000001